Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;26(3):227-233.
doi: 10.5213/inj.2244084.042. Epub 2022 Sep 30.

Data Gap in Sacral Neuromodulation Documentation: Call to Improve Documentation Protocols

Affiliations

Data Gap in Sacral Neuromodulation Documentation: Call to Improve Documentation Protocols

Christopher M Hornung et al. Int Neurourol J. 2022 Sep.

Abstract

Purpose: We quantified patient record documentation of sacral neuromodulation (SNM) threshold testing and programming parameters at our institution to identify opportunities to improve therapy outcomes and future SNM technologies.

Methods: A retrospective review was conducted using 127 records from 40 SNM patients. Records were screened for SNM documentation including qualitative and quantitative data. The qualitative covered indirect references to threshold testing and the quantitative included efficacy descriptions and device programming used by the patient. Findings were categorized by visit type: percutaneous nerve evaluation (PNE), stage 1 (S1), permanent lead implantation, stage 2 (S2) permanent impulse generator implantation, device-related follow-up, or surgical removal.

Results: Documentation of threshold testing was more complete during initial implant visits (PNE and S1), less complete for S2 visits, and infrequent for follow-up clinical visits. Surgical motor thresholds were most often referred to using only qualitative comments such as "good response" (88%, 100% for PNE, S1) and less commonly included quantitative values (68%, 84%), locations of response (84%, 83%) or specific contacts used for testing (0%). S2 motor thresholds were less well documented with qualitative, quantitative, and anatomical location outcomes at 70%, 48%, and 36% respectively. Surgical notes did not include specific stimulation parameters or contacts used for tests. Postoperative sensory tests were often only qualitative (80%, 67% for PNE, S1) with quantitative values documented much less frequently (39%, 9%) and typically lacked sensory locations or electrode-specific results. For follow-up visits, <10% included quantitative sensory test outcomes. Few records (<7%) included device program settings recommended for therapy delivery and none included therapy-use logs.

Conclusion: While evidence suggests contact and parameter-specific programming can improve SNM therapy outcomes, there is a major gap in the documentation of this data. More detailed testing and documentation could improve therapeutic options for parameter titration and provide design inputs for future technologies.

Keywords: Electronic health records; Implantable neurostimulators; Retrospective study; Urinary incontinence.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1.
Fig. 1.
Patient sacral neuromodulation (SNM) care pathway and records analyzed. Records for 40 patients were reviewed and summarized for the SNM care pathway. A total of 127 visits were included. The number of visit records are shown in the parentheses for each clinical or surgical visit type. PNE, percutaneous nerve evaluation.
Fig. 2.
Fig. 2.
Sacral neuromodulation (SNM) motor threshold outcomes included in patient records. Within each surgery visit type, % of records including the test outcomes are shown. The number of surgical records is included in the parentheses. Zeros indicate no records included the outcome.
Fig. 3.
Fig. 3.
Sacral neuromodulation (SNM) sensory threshold outcomes included in patient records. Within each visit type, % of records including the test outcomes are shown. The number of records for each visit type is in parentheses. Zeros indicate no visit records included the outcome.

References

    1. Bosch JL, Groen J. Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. J Urol. 2000;163:1219–22. - PubMed
    1. Wöllner J, Hampel C, Kessler TM. Sacral neuromodulation: surgery illustrated. BJU Int. 2012;110:146–59. - PubMed
    1. De Wachter S, Vaganee D, Kessler TM. Sacral neuromodulation: mechanism of action. Eur Urol Focus. 2020;6:823–5. - PubMed
    1. Lehur PA, Sørensen M, Dudding TC, Knowles CH, Wachter S, Engelberg S, et al. Programming algorithms for sacral neuromodulation: clinical practice and evidence—recommendations for day‐ to‐day practice. Neuromodulation. 2020;23:1121–9. - PMC - PubMed
    1. Lee J, Osann K, Noblett K. Comparison of motor and sensory response of InterStim® for overactive bladder syndrome. Female Pelvic Med Reconstr Surg. 2013;19:317–21. - PubMed

LinkOut - more resources